Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2021-03-03 AGM Information
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Result of General Meeting & Total Voting Rights
AGM Information Classification · 1% confidence The document is clearly identified as an RNS Number (0583R) announcement from Evgen Pharma PLC dated March 3, 2021. The content explicitly details the 'Result of General Meeting' including voting tallies, and subsequently provides 'Total Voting Rights' information. Crucially, it also includes detailed sections reporting insider transactions ('Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')') which are typically filed under DIRS or RNS. Since the primary focus is the outcome of a shareholder vote (General Meeting Results) and the announcement is distributed via RNS, the most specific classification covering shareholder voting results is DVA (Declaration of Voting Results & Voting Rights Announcements). While it contains insider trading details (DIRS), the context is framed around the General Meeting outcome and total voting rights update, making DVA highly relevant. However, given the presence of the RNS header and the dual nature (Meeting Results + PDMR transactions), RNS is a strong fallback. Since DVA specifically covers 'Official results from shareholder votes at any general meeting (AGM or EGM)', and the document explicitly states 'Result of General Meeting' and provides the poll results, DVA is the most precise fit for the primary subject matter, even though it is distributed via RNS.
2021-03-03 English
Result of Open Offer
Share Issue/Capital Change Classification · 1% confidence The document is identified by the RNS Number (9327Q) and the date (03 March 2021), indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content explicitly announces the 'Result of Open Offer' related to a fundraising effort (£11 million) involving the issuance of New Ordinary Shares. This type of announcement, detailing the outcome of a capital raise or share issuance, fits best under the 'Capital/Financing Update' (CAP) category. Although it mentions a General Meeting, the primary focus is the financial transaction result, not the meeting materials themselves (which would be AGM-R or PSI). It is a specific announcement, not a general regulatory filing fallback (RNS).
2021-03-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 5763Q' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange, approved by the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings' concerning SPREADEX LTD's acquisition/disposal of voting rights in Evgen Pharma PLC. This type of mandatory disclosure regarding changes in significant share ownership thresholds falls directly under the definition of Major Shareholding Notification (MRQ).
2021-02-26 English
Notice of AGM & Posting Annual Report and Accounts
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3221 characters) released via RNS (London Stock Exchange news service). The title explicitly states: 'Notice of Annual General Meeting and Posting of Annual Report and Accounts'. It informs the reader that the audited accounts and the AGM notice are now available on the website and will be posted to shareholders today. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report (Annual Report/Accounts) and a meeting notice (AGM) is best classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), rather than the full report (10-K or AR) or the AGM material (AGM-R) itself. Since it specifically announces the publication of reports and the AGM notice, RPA is the most precise fit, as it signals the release of other documents. If RPA were not available, RNS would be the fallback. Given the options, RPA captures the essence of announcing the availability of reports.
2021-02-25 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, identified by the RNS Number '2510Q'. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved by the FCA to act as a Primary Information Provider. This type of short, specific regulatory announcement that doesn't fit into detailed financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2021-02-24 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly mentions 'RNS Number', 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider', and ends with RNS-specific boilerplate text. The content itself is a very brief announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange. This is a general regulatory announcement that does not fit into specific categories like 10-K, ER, or DIV. Therefore, it falls under the general Regulatory Filings category.
2021-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.